Back to Search
DAVID CURLEY, M.D.
M.D.
Emergency Medicine Physician
NPI: 1831413806IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
UNIVERSITY OF VERMONT COLLEGE OF MEDICINE
Class of 2010
Research & Publications (19)
Endogenous suppression of mast cell development and survival by IL-4 and IL-10.
PMID 19228815·J Leukoc Biol·2009
7-preclinical
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.
PMID 19282848·Nat Genet·2009
7-preclinical
A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin.
PMID 18353136·Pigment Cell Melanoma Res·2008
7-preclinical
Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
PMID 17575131·Cancer Res·2007
7-preclinical
Epigenetic silencing of novel tumor suppressors in malignant melanoma.
PMID 17145863·Cancer Res·2006
7-preclinical
Ethical questions to ponder in the European stem cell patent debate.
PMID 17152135·J Biolaw Bus·2006
8-other
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.
PMID 16676322·Genesis·2006
7-preclinical
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model.
PMID 16116483·Oncogene·2005
7-preclinical
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.
PMID 15784726·Blood·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 593 EDDY ST
PROVIDENCE, RI 02903 - Phone
- (401) 444-5175
Quick Facts
- NPI
- 1831413806
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 16
- Publications
- 19
Are you this provider?
Claim Your Profile